Soleno Therapeutics Inc.

NASDAQ: SLNO · Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:44 PM
66.00
-14.68%
Pre-market: Aug 15, 2025, 09:28 AM EDT

Soleno Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 1.96M 2.21M 2.21M
Gross Profit
n/a -1.96M -2.21M -2.21M
Operating Income
-184.43M -41.38M -24.4M -31.53M
Interest Income
n/a 2.58M 300K 110K
Pretax Income
-175.85M -38.99M -24.07M -30.91M
Net Income
-175.85M -38.99M -20.32M -29.56M
Selling & General & Admin
105.86M 13.48M 9.84M 10.81M
Research & Development
78.57M 25.19M 15.27M 21.45M
Other Expenses
n/a 2.71M n/a n/a
Operating Expenses
187.67M 41.38M 25.11M 32.26M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 41.38M 25.11M 32.26M
Income Tax Expense
n/a n/a -3.75M -1.35M
Shares Outstanding (Basic)
40.18M 16.49M 8.4M 5.32M
Shares Outstanding (Diluted)
40.18M 16.49M 8.4M 5.32M
EPS (Basic)
-4.38 -2.36 -2.42 -5.56
EPS (Diluted)
-4.38 -2.36 -2.42 -5.56
EBITDA
-173.63M -37.03M -21.86M -28.7M
EBIT
-175.62M -38.99M -24.07M -32.26M
Depreciation & Amortization
n/a 1.96M 2.21M 2.21M